ARCHIVES

Guideline Revisions or Outstanding Investigator Grant Still Controversial

This article is from The Cancer Letter archive.

Vol. 09 No. 47 | December 9, 1983

Download PDF Visit The Full Archive

Related Articles

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

November 25, 2011

Kington Named Acting NIH Director.

November 14, 2008

CIS Cost Sharing Feasibility Study Recommended

December 11, 1987

Patient Costs In Trials Should Be Paid In Any Reform Plan, DCT Board Write To Shalala

June 18, 1993

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007

Obama’s Virtual Colonoscopy Sets Off Real-World Turf War Of Specialty Groups.

March 5, 2010